Michael Saag, MD

Michael Saag, MD

Infectious Disease Birmingham, AL

Professor of Medicine, University Alabama


Office Address

  • 619 19th Street South
    UAB Div Infectious Diseases
    Birmingham, AL 35233
    Phone: (205) 934-6600

Michael Saag, MD

Infectious Disease Birmingham, AL

Professor of Medicine, University Alabama

Clinical Specialties & Interests

  • Infectious Disease: General Infectious Disease, HIV/AIDS Medicine
  • Clinical Interests: HIV outcomes research, HCV treatment, international health; HIV Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Highly Active Antiretroviral Therapy; Viral Load; Retrospective Studies; HIV-1; Drug Administration Schedule; HIV

Education & Training

  • University of Alabama Medical CenterUniversity of Alabama Medical Center
  • University of Alabama Medical CenterUniversity of Alabama Medical Center
  • University of Louisville School of MedicineUniversity of Louisville School of Medicine

Certifications & Licensure

  • AL State Medical LicenseAL State Medical License1982 - 2015
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineInfectious Disease

    Awards, Honors, & Recognition

    • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002
    • Elected MemberThe American Society for Clinical Investigation, 1997
    • Whos Who in Medicine and HealthcareMarquis Whos Who

    Clinical Trials

    Publications & Presentations

    PubMed

    Lectures

    • Screening in Emergency Department Identifies a Large Cohort of Unrecognized Chronic Hepatitis C Virus Infection among Baby Boomers University of Alabama at Birmingham, Birmingham, AL - 5/15/2014

    Grant Support

    • Integration Of Evidence-Based Alcohol Interventions Into HIV CareNational Institute On Alcohol Abuse And Alcoholism
      2011 - 2011
    • Recent Advances In AIDS And HIV ResearchNational Institute Of Allergy And Infectious Diseases
      2009 - 2011
    • Administrative CoreNational Institute Of Allergy And Infectious Diseases
      2009 - 2011
    • AdministrativeNational Institute Of Allergy And Infectious Diseases
      2008 - 2008
    • ACTG A5229National Center For Research Resources
      2007 - 2007
    • Alabama-Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
      2007 - 2012
    • ACTG A5209 Ezetimibe (ZETIA) In Combination With Statin Therapy For The TreatmenNational Center For Research Resources
      2006 - 2007
    • A5202, Final Version 10, 05/05/05: Initial Therapy With Different AntiretroviraNational Center For Research Resources
      2006 - 2007
    • ACTG A5142, V 20National Center For Research Resources
      2006 - 2006
    • Unsolicited R24 For The Cfar-Network Of Integrated Clinical Sciences, CnicsNational Institute Of Allergy And Infectious Diseases
      2006 - 2011
    • ACTG A5001 (V 30)National Center For Research Resources
      2006 - 2007
    • FRAM 2National Center For Research Resources
      2005 - 2007
    • Silcaat V 40National Center For Research Resources
      2005 - 2007
    • ACTG A5146National Center For Research Resources
      2005 - 2007
    • ACTG A5186National Center For Research Resources
      2005 - 2006
    • ACTG A5178 (Slam-C)National Center For Research Resources
      2005 - 2006
    • Amd11070 In Hiv-Positive Subjects (A5210)National Center For Research Resources
      2005 - 2007
    • ACTG A5174 Improving Immune Reconstitution With Growth Hormone In Hiv-InfectedNational Center For Research Resources
      2005 - 2005
    • ACTG A5142, V 20 Comparison Of Lopinavir/Ritonavir PLUS Efavirenz VS Lopinavir/National Center For Research Resources
      2005 - 2005
    • ACTG A5001 (V 20) Adult AIDS Clinical Trials Group Longitudinal Linked RandomizNational Center For Research Resources
      2005 - 2005
    • ACTG 5095 Comparison Of Three Protease Inhibitor-Sparing Regimens For The InitiaNational Center For Research Resources
      2005 - 2005
    • ACTG 5095 Comparison Of Three Protease InhibitorNational Center For Research Resources
      2004 - 2004
    • ACTG A5068National Center For Research Resources
      2004 - 2007
    • ACTG A5181National Center For Research Resources
      2004 - 2005
    • UAB Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases
      2004 - 2011
    • Improving Immune Reconstitution With Growth HormoneNational Center For Research Resources
      2004 - 2004
    • Adult AIDS Clinical Trials Group Longitudinal LinkedNational Center For Research Resources
      2004 - 2004
    • Comparison Of Lopinavir/Ritonavir PLUS EfavirenzNational Center For Research Resources
      2004 - 2004
    • Recent Advances In AIDS And HIV ResearchNational Institute Of Allergy And Infectious Diseases
      2003 - 2007
    • Adult AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases
      2000 - 2007
    • Viral/Lymphocyte Dynamics In HIV-1 Infected PatientsNational Center For Research Resources
      2000 - 2000
    • Core--ClinicalNational Institute Of Allergy And Infectious Diseases
      1998 - 2002
    • T20 Administered To HIV1 Positive AdultsNational Center For Research Resources
      1998 - 1999
    • Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Outreach AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Neurology AgendaNational Institute Of Allergy And Infectious Diseases
      1997 - 1999
    • Antiviral Activity Of GEM 91 In HIV Positive AdultsNational Center For Research Resources
      1996 - 1996
    • Oral Prednisone In HIV Infection With Unexplained Weight LossNational Center For Research Resources
      1996 - 1997
    • AMP B/Flucytosin VS AMP B/Fluconazole In Acute Cryptococcal MeningitisNational Center For Research Resources
      1995 - 1995
    • Itraconazole And Fluconazole In Relapse Of Aids-Related Cryptococcal MeningitisNational Center For Research Resources
      1995 - 1995
    • AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases
      1994 - 1995
    • Pharmacokinetics In HIV Infected AdultsNational Center For Research Resources
      1993 - 1993
    • Recombinant Cd4-Immunoglobulin In HIV Infection And Sensitivity To Rcd4-IggNational Center For Research Resources
      1993 - 1995
    • Trimetrexate W/Leucovorin CA Rescue VS Pentamidine In AIDSNational Center For Research Resources
      1992 - 1995
    • L-697,661 Compared To AZT In HIV Sero-Positive PatientsNational Center For Research Resources
      1992 - 1995
    • Randomized Double-Blind Protocol In Acute Crytococcal MeningitisNational Center For Research Resources
      1992 - 1995
    • SCH 39304 For Acute Cryptococal Meningitis In HIV Infected PatientsNational Center For Research Resources
      1992 - 1993
    • SCH 39304 To Patients With Advanced HIV InfectionNational Center For Research Resources
      1992 - 1995
    • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
      1992 - 1999
    • Trimetrexate W/Leucovorin CA Rescue VS Trimethoprim/SulfamethoxazoleNational Center For Research Resources
      1990 - 1990
    • Trimetrexate VS IV Pentamidine In AIDS Patients With PCP Refractory To T/SNational Center For Research Resources
      1990 - 1990
    • Pharmacokinetic Study Of Single 600mg Oral Dose Of Sch39304National Center For Research Resources
      1990 - 1990
    • Maintenance Fluconazole And Amphotericin B For Crypto Meningitis In AIDSNational Center For Research Resources
      1990 - 1990

    Hospital Affiliations

    Insurance Accepted

    • Anthem PPO
    • BCBS Alabama PPO
    • BCBS Blue Card PPO
    • CIGNA HMO
    • CIGNA Open Access
    • CIGNA PPO
    • First Health PPO
    • Great West PPO
    • Healthfirst New York
    • Humana ChoiceCare Network PPO
    • Multiplan PHCS PPO
    • Multiplan PPO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO
    • The full profile is locked and available to verified physicians only.
      Join over 60% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Saag's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV